Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Pharmaceuticals (Basel, Switzerland)|May 25, 2024
Mechanistic Sequence of Histone Deacetylase Inhibitors and Radiation Treatment: An OverviewElsie Neo Seane, Shankari Nair, Charlot Vandevoorde, et al.Pharmaceuticals (Basel, Switzerland)|November 27, 2024
Multi-Target Inhibitor CUDC-101 Impairs DNA Damage Repair and Enhances Radiation Response in Triple-Negative Breast Cell LineElsie Neo Seane, Shankari Nair, Charlot Vandevoorde, et al.Theranostics|August 2, 2021
A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastomaJulie Bolcaen, Janke Kleynhans, Shankari Nair, et al.Pharmaceuticals (Basel, Switzerland)|July 2, 2021
Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of GlioblastomaJulie Bolcaen, Shankari Nair, Cathryn H S Driver, et al.Cancers|April 12, 2022
Perspective on the Use of DNA Repair Inhibitors as a Tool for Imaging and Radionuclide Therapy of GlioblastomaLiesbeth Everix, Shankari Nair, Cathryn H S Driver, et al.International Journal of Molecular Sciences|October 31, 2019
The Impact of Dose Rate on DNA Double-Strand Break Formation and Repair in Human Lymphocytes Exposed to Fast Neutron IrradiationShankari Nair, Monique Engelbrecht, Xanthene Miles, et al.Bioorganic Chemistry|August 23, 2022
Synthesis and evaluation of benzoylbenzofurans and isoflavone derivatives as sirtuin 1 inhibitors with antiproliferative effects on cancer cellsMamoalosi A Selepe, Phaladi Kunyane, Pule Seboletswe, et al.Journal of Visualized Experiments : Jove|January 10, 2022
An Automated Microscopic Scoring Method for the γ-H2AX Foci Assay in Human Peripheral Blood LymphocytesShankari Nair, Samantha Cairncross, Xanthene Miles, et al.Scientific Reports|October 22, 2021
DNA damage response of haematopoietic stem and progenitor cells to high-LET neutron irradiationMonique Engelbrecht, Roya Ndimba, Maryna de Kock, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2024
Preclinical Efficacy of a PSMA-Targeted Actinium-225 Conjugate (225Ac-Macropa-Pelgifatamab): A Targeted Alpha Therapy for Prostate CancerChristoph A Schatz, Sabine Zitzmann-Kolbe, Ingrid Moen, et al.Pageof 1